9H11
 
 | | Crystal structure of OXA-48 apoenzyme | | Descriptor: | Beta-lactamase, CHLORIDE ION, GLYCEROL | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.38 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9H16
 | | Crystal structure of OXA-405 apoenzyme | | Descriptor: | 1,2-ETHANEDIOL, Beta-lactamase, CHLORIDE ION, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.56 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9H15
 | | Crystal structure of OXA-163 in complex with nacubactam | | Descriptor: | (2S,5R)-N-(2-aminoethoxy)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, 1,2-ETHANEDIOL, Beta-lactamase, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (2.18 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9HPV
 | | Crystal structure of OXA-163 in complex with nacubactam (16 hour soak) | | Descriptor: | (2S,5R)-N-(2-aminoethoxy)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, (2S,5R)-N-(2-azanylethoxy)-1-methanoyl-5-(oxidanylamino)piperidine-2-carboxamide, 1,2-ETHANEDIOL, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-12-16 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.41 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9H18
 | | Crystal structure of OXA-405 in complex with nacubactam | | Descriptor: | (2S,5R)-N-(2-aminoethoxy)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, (2S,5R)-N-(2-azanylethoxy)-1-methanoyl-5-(oxidanylamino)piperidine-2-carboxamide, 1,2-ETHANEDIOL, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.33 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9H17
 | | Crystal structure of OXA-405 in complex with avibactam | | Descriptor: | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, (2S,5R)-1-methanoyl-5-(oxidanylamino)piperidine-2-carboxamide, 1,2-ETHANEDIOL, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.46 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9H13
 | | Crystal structure of OXA-163 apoenzyme | | Descriptor: | 1,2-ETHANEDIOL, Beta-lactamase, CHLORIDE ION, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.44 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9H14
 | | Crystal structure of OXA-163 in complex with avibactam | | Descriptor: | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, (2S,5R)-1-methanoyl-5-(oxidanylamino)piperidine-2-carboxamide, 1,2-ETHANEDIOL, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.56 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
9H12
 | | Crystal structure of OXA-48 in complex with nacubactam | | Descriptor: | (2S,5R)-N-(2-aminoethoxy)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, 1,2-ETHANEDIOL, Beta-lactamase, ... | | Authors: | Hoff, J.F, Goudar, K.E, Hinchliffe, P, Spencer, J. | | Deposit date: | 2024-10-09 | | Release date: | 2025-09-03 | | Last modified: | 2025-09-24 | | Method: | X-RAY DIFFRACTION (1.51 Å) | | Cite: | Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like beta-lactamases.
Rsc Med Chem, 2025
|
|
